par Beex, Louk;Rose, Carsten;Mouridsen, Henning;Jassem, J.;Nooij, Marianne;Estape, J.;Paridaens, R. ;Piccart-Gebhart, Martine ;Gorlia, Thierry;Lardenoije, S.;Baila, L.
Référence European journal of cancer, 42, 18, page (3178-3185)
Publication Publié, 2006-12
Référence European journal of cancer, 42, 18, page (3178-3185)
Publication Publié, 2006-12
Article révisé par les pairs
Titre: |
|
Auteur: | Beex, Louk; Rose, Carsten; Mouridsen, Henning; Jassem, J.; Nooij, Marianne; Estape, J.; Paridaens, R.; Piccart-Gebhart, Martine; Gorlia, Thierry; Lardenoije, S.; Baila, L. |
Informations sur la publication: | European journal of cancer, 42, 18, page (3178-3185) |
Statut de publication: | Publié, 2006-12 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Advanced breast cancer |
Alternated endocrine therapy | |
Intermittent endocrine therapy | |
Medroxyprogesterone acetate | |
Randomised study | |
Tamoxifen | |
MeSH keywords: | Adult |
Aged | |
Aged, 80 and over | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Disease-Free Survival | |
Drug Resistance, Neoplasm | |
Female | |
Humans | |
Medroxyprogesterone Acetate -- administration & dosage | |
Medroxyprogesterone Acetate -- adverse effects | |
Middle Aged | |
Tamoxifen -- administration & dosage | |
Tamoxifen -- adverse effects | |
Note générale: | Clinical Trial, Phase III |
Comparative Study | |
Journal Article | |
Randomized Controlled Trial | |
Research Support, N.I.H., Extramural | |
Langue: | Anglais |
Identificateurs: | urn:issn:0959-8049 |
info:doi/10.1016/j.ejca.2006.08.020 | |
info:pii/S0959-8049(06)00765-9 | |
info:scp/33845224929 | |
info:pmid/17045796 |